Michelle Hermiston

Michelle Hermiston is a Professor in the Department of Pediatrics at the University of California San Francisco (UCSF) School of Medicine. With dual MD and PhD degrees from Washington University and a residency/fellowship in pediatrics and hematology/oncology at UCSF, she specializes in pediatric leukemia, immunology, and hematopoietic stem cell transplantation research.

• Education: B.S. in Physiology (University of Iowa, 1988), Ph.D. in Developmental Biology (Washington University, 1997), M.D. (Washington University, 1997)
• Training: Pediatrics residency (UCSF, 1997-99), Hematology/Oncology fellowship (UCSF, 1999-03), Immunology postdoc (UCSF, 2001-07)

Her research focuses on pediatric T-cell acute lymphoblastic leukemia (T-ALL), lupus pathogenesis, CD45 protein function, and transplantation immunology. She has led NIH-funded studies on T-ALL risk allocation (R01CA193776) and lupus immune mechanisms (R01AI089831), with over 20 years of active grants.

Key recent publications address immunotherapy dosing strategies, graft rejection minimization, conditioning regimen toxicity, and global oncology frameworks. Her work appears in journals like Blood, Transplantation and Cellular Therapy, and Cancer.

• Awards: Alpha Omega Alpha (1997), St. Baldrick's Foundation Young Investigator (2009), Alex Lemonade Stand Young Investigator (2010), FASEB Poster Award (2005)
• Leadership: Co-Principal Investigator for NIH grants, mentorship award nominee, collaborative trial participant (COG, NACHO)